力诺药包1月22日获融资买入2023.35万元，融资余额1.94亿元

Group 1 - The core viewpoint of the news highlights the trading performance and financial metrics of Linuo Pharmaceutical Packaging Co., Ltd., indicating a significant increase in financing activities and a decrease in revenue and net profit [1][2]. Group 2 - On January 22, Linuo Pharmaceutical's stock rose by 1.58%, with a trading volume of 95.04 million yuan. The financing buy-in amount for the day was 20.23 million yuan, while the net financing buy-in reached 12.20 million yuan [1]. - As of January 22, the total balance of margin trading for Linuo Pharmaceutical was 195 million yuan, accounting for 4.36% of its market capitalization, indicating a high level of financing activity [1]. - The company reported a total revenue of 721 million yuan for the period from January to September 2025, reflecting a year-on-year decrease of 13.22%. The net profit attributable to shareholders was 50.88 million yuan, down 27.80% year-on-year [2]. - The company has distributed a total of 139 million yuan in dividends since its A-share listing, with 92.18 million yuan distributed over the past three years [2]. - As of September 30, 2025, the number of shareholders increased to 17,600, a rise of 58.60%, while the average circulating shares per person decreased by 36.94% to 13,571 shares [2].